1. Home
  2. ASMB vs USCB Comparison

ASMB vs USCB Comparison

Compare ASMB & USCB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Assembly Biosciences Inc.

ASMB

Assembly Biosciences Inc.

HOLD

Current Price

$26.75

Market Cap

442.9M

Sector

Health Care

ML Signal

HOLD

Logo USCB Financial Holdings Inc.

USCB

USCB Financial Holdings Inc.

HOLD

Current Price

$20.27

Market Cap

368.2M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
ASMB
USCB
Founded
2005
2002
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Major Banks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
442.9M
368.2M
IPO Year
2010
2021

Fundamental Metrics

Financial Performance
Metric
ASMB
USCB
Price
$26.75
$20.27
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
5
2
Target Price
$44.20
$23.00
AVG Volume (30 Days)
245.6K
58.2K
Earning Date
05-06-2026
04-23-2026
Dividend Yield
N/A
2.72%
EPS Growth
91.78
7.26
EPS
N/A
0.51
Revenue
N/A
N/A
Revenue This Year
N/A
$26.46
Revenue Next Year
$638.39
$9.67
P/E Ratio
N/A
$39.67
Revenue Growth
N/A
N/A
52 Week Low
$16.90
$16.06
52 Week High
$39.71
$20.93

Technical Indicators

Market Signals
Indicator
ASMB
USCB
Relative Strength Index (RSI) 50.41 57.51
Support Level $26.18 $17.65
Resistance Level $30.68 $20.86
Average True Range (ATR) 1.46 0.56
MACD 0.01 -0.06
Stochastic Oscillator 46.08 60.42

Price Performance

Historical Comparison
ASMB
USCB

About ASMB Assembly Biosciences Inc.

Assembly Biosciences Inc is a clinical-stage biotechnology company. The Company's pipeline includes multiple clinical-stage investigational therapies, including: (1) two long-acting helicase-primase inhibitors (HPI) for the treatment of recurrent genital herpes; (2) an orally bioavailable hepatitis delta virus entry inhibitor; and (3) a potent next-generation capsid assembly modulator designed to disrupt the replication cycle of hepatitis B virus (HBV) at several key points. The Company's pipeline also includes a novel, oral broad-spectrum non-nucleoside polymerase inhibitor (NNPI) for the treatment of transplant-related herpesviruses.

About USCB USCB Financial Holdings Inc.

USCB Financial Holdings Inc is a bank holding company. Through its banking subsidiary, it offers relationship-based banking products, services, and solutions to a diverse set of clients in the local markets it operates in and international clients with U.S. banking needs. The Group's products and services offerings mainly include traditional deposit products, including commercial and consumer checking accounts, money market deposit accounts, savings accounts, etc.; e-banking services; title insurance policies for real estate transactions; and a variety of lending products such as small business loans, commercial real estate loans, business credit cards, etc.; and others. Geographically, its primary banking market is South Florida.

Share on Social Networks: